Filing Details

Accession Number:
0001213900-13-003306
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-26 16:18:17
Reporting Period:
2013-06-25
Filing Date:
2013-06-26
Accepted Time:
2013-06-26 16:18:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
812796 Soligenix Inc. SNGX Pharmaceutical Preparations (2834) 411505029
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1068029 J Christopher Schaber 29 Emmons Drive, Suite C-10
Princeton NJ 08540
Chairman, Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-25 9,523 $1.05 59,681 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants Acquisiton 2013-06-25 7,143 $0.00 7,143 $1.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,142 2013-06-25 2018-06-25 No 4 P Direct